Knowledge, attitude and practice about human papilloma virus vaccination among medical students

Hardika Poonia; Deepa Lokwani Masand

doi:10.18203/2320-1770.ijrcog20253519

Authors

Hardika Poonia Department of Obstetrics and Gynaecology, JNU Medical College, Jaipur, Rajasthan, India
Deepa Lokwani Masand Department of Obstetrics and Gynaecology, JNU Medical College, Jaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20253519

Keywords:

HPV, Cervical cancer, Vaccination, Medical students, Awareness, Preventive healthcare

Abstract

Background: Human papilloma virus (HPV) is one of the most common sexually transmitted infections and a major etiological factor for cervical cancer, which remains a leading cause of morbidity and mortality among women worldwide. Although safe and effective vaccines are available, awareness and vaccination coverage remain suboptimal, especially among young adults. Medical students, as future healthcare providers, play a pivotal role in promoting HPV vaccination; therefore, understanding their knowledge, attitude, and practices (KAP) is essential.

Methods: A cross-sectional study was conducted among undergraduate medical students of JNU medical college, Jaipur. Data were collected using a structured, pretested questionnaire assessing participants’ knowledge about HPV infection and vaccination, their attitudes toward immunization, and their personal vaccination practices. The responses were analysed using descriptive statistics to determine awareness levels and the relationship between knowledge and vaccination behaviour.

Results: The study revealed that while a majority of students had heard about HPV and its association with cervical cancer, only a smaller proportion demonstrated adequate knowledge about the recommended age, dosage schedule, and target groups for vaccination. Attitude toward HPV vaccination was generally positive, but the actual practice of vaccination among students was low. A clear gap was observed between awareness and vaccine uptake.

Conclusions: Although medical students showed moderate awareness and positive attitudes toward HPV vaccination, poor vaccination practice highlights the need for targeted educational programs and inclusion of HPV-related content in the medical curriculum.

Metrics

Metrics Loading ...

References

Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002;55(4):244-65. DOI: https://doi.org/10.1136/jcp.55.4.244

Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, et al. Human papillomavirus and related diseases in the world: summary report. ICO/IARC Information Centre on HPV and Cancer. 2024.

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon (France): International Agency for Research on Cancer. 2022.

Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):1-9. DOI: https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F

Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, et al. Quadrivalent human papillomavirus vaccine: recommendations of the ACIP. MMWR Recomm Rep. 2007;56(RR-2):1-24. DOI: https://doi.org/10.1037/e601292007-001

Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with HPV types 16 and 18. Lancet. 2004;364(9447):1757-65. DOI: https://doi.org/10.1016/S0140-6736(04)17398-4

World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017;92(19):241-68.

Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: considerations for school- and non-school-based immunization programs. Vaccine. 2014;32(3):320-6. DOI: https://doi.org/10.1016/j.vaccine.2013.11.070

Ladner J, Besson MH, Hampshire R, Tapert L, Chao S, Audureau E, et al. Assessment of eight HPV vaccination programs implemented in lowest-income countries. BMC Public Health. 2012;12:370. DOI: https://doi.org/10.1186/1471-2458-12-370

Rashid S, Labani S, Das BC. Knowledge, awareness and attitude on HPV, HPV vaccine and cervical cancer among college students in India. PLoS One. 2016;11(11):e0166713. DOI: https://doi.org/10.1371/journal.pone.0166713

Pandey D, Vanya V, Bhagat S, Binu VS, Shetty J. Awareness and attitude towards human papillomavirus (HPV) vaccine among medical students in a medical school in India. PLoS One. 2012;7(7):e40619. DOI: https://doi.org/10.1371/journal.pone.0040619

Dany M, Chidiac A, Nassar AH. Human papillomavirus vaccination: assessing knowledge, attitudes, and intentions of college female students in Lebanon, a developing country. Vaccine. 2015;33(8):1001-7. DOI: https://doi.org/10.1016/j.vaccine.2015.01.009

Arrossi S, Paolino M, Laudi R, Gago J, Basiletti J, Ramirez J, et al. Acceptability and uptake of HPV vaccine in Argentina: a population-based study. Vaccine. 2019;37(1):107-13.

Patel H, Wilson E, Vizzotti C, Bedford J, Figueroa JP, Pallas SW, et al. HPV vaccine introduction: the role of health systems in facilitating global equity. Vaccine. 2020;38(40):6232-9.

Drolet M, Bénard É, Pérez N, Brisson M, Ali H, Boily MC, et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. Lancet. 2019;394(10197):497-509. DOI: https://doi.org/10.1016/S0140-6736(19)30298-3

Mehta S, Rajaram S, Goel G, Agarwal N, Chopra S, Arora R, et al. Awareness and acceptability of HPV vaccine among medical students in North India. J Obstet Gynaecol India. 2018;68(6):432-7.

Gallagher KE, LaMontagne DS, Watson-Jones D. Status of HPV vaccine introduction and barriers to country uptake. Vaccine. 2018;36(32):4761-7. DOI: https://doi.org/10.1016/j.vaccine.2018.02.003

Bruni L, Saura-Lázaro A, Montoliu A, Brotons M, Alemany L, Guimerà N, et al. HPV vaccination introduction worldwide and WHO/UNICEF estimates of national coverage 2010-2019. Prev Med. 2021;144:106399. DOI: https://doi.org/10.1016/j.ypmed.2020.106399

Cutts FT, Gallagher KE, Li X, Cuzick J, Broutet N, de Sanjosé S, et al. Human papillomavirus vaccine introduction: the real-world impact on cervical cancer prevention. Int J Gynaecol Obstet. 2022;157(2):311-8.

Deshmukh AA, Suk R, Shiels MS, Stier EA, Chiao EY, Nyitray AG, et al. Estimation of lifetime quality-adjusted life-years gained from HPV vaccination. JAMA Netw Open. 2020;3(7):e2010184.

Umeh IB, Nduka CU, Ekwunife OI, Okafor CE, Ezeoke UE, Uzochukwu BS, et al. Mothers’ willingness to pay for HPV vaccination in Nigeria: implications for national immunization policy. BMC Public Health. 2021;21:1928.

Patel C, Brotherton JML, Pillsbury A, Donovan B, Macartney K, Kaldor JM, et al. The impact of 10 years of HPV vaccination in Australia: what has been achieved and what remains to be done? Future Microbiol. 2018;13(5):639-54.